This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2h5s

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2h5s.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2h5s.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2h5s| PDB=2h5s | SCENE= }}
{{STRUCTURE_2h5s| PDB=2h5s | SCENE= }}
-
'''SA2-13 penam sulfone complexed to wt SHV-1 beta-lactamase'''
+
===SA2-13 penam sulfone complexed to wt SHV-1 beta-lactamase===
-
==Overview==
+
<!--
-
beta-Lactamases are one of the major causes of antibiotic resistance in Gram negative bacteria. The continuing evolution of beta-lactamases that are capable of hydrolyzing our most potent beta-lactams presents a vexing clinical problem, in particular since a number of them are resistant to inhibitors. The efficient inhibition of these enzymes is therefore of great clinical importance. Building upon our previous structural studies that examined tazobactam trapped as a trans-enamine intermediate in a deacylation deficient SHV variant, we designed a novel penam sulfone derivative that forms a more stable trans-enamine intermediate. We report here the 1.28 A resolution crystal structure of wt SHV-1 in complex with a rationally designed penam sulfone, SA2-13. The compound is covalently bound to the active site of wt SHV-1 similar to tazobactam yet forms an additional salt-bridge with K234 and hydrogen bonds with S130 and T235 to stabilize the trans-enamine intermediate. Kinetic measurements show that SA2-13, once reacted with SHV-1 beta-lactamase, is about 10-fold slower at being released from the enzyme compared to tazobactam. Stabilizing the trans-enamine intermediate represents a novel strategy for the rational design of mechanism-based class A beta-lactamase inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17017804}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17017804 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17017804}}
==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Beta-lactamase inhibitor]]
[[Category: Beta-lactamase inhibitor]]
[[Category: Drug design]]
[[Category: Drug design]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 05:54:06 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 12:07:44 2008''

Revision as of 09:07, 28 July 2008

Image:2h5s.png

Template:STRUCTURE 2h5s

SA2-13 penam sulfone complexed to wt SHV-1 beta-lactamase

Template:ABSTRACT PUBMED 17017804

About this Structure

2H5S is a Single protein structure of sequence from Klebsiella pneumoniae. Full crystallographic information is available from OCA.

Reference

Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone., Padayatti PS, Sheri A, Totir MA, Helfand MS, Carey MP, Anderson VE, Carey PR, Bethel CR, Bonomo RA, Buynak JD, van den Akker F, J Am Chem Soc. 2006 Oct 11;128(40):13235-42. PMID:17017804

Page seeded by OCA on Mon Jul 28 12:07:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2h5s"
Personal tools